About PanGenomic
PanGenomic is a publicly listed company based in Vancouver (Canada) founded in 2020 by Vincent Lum and Robert Nygren. Online teleconsultation for plant-based mental health therapies is facilitated. PanGenomic has completed 1 acquisition, including MindLeap. Its chief executive, as recorded, is Vincent Lum. PanGenomic offers products and services including Nara, Mindleap, PlantGx, and MUJN Diagnostics. Its focus areas include HealthTech, Healthcare Booking Platforms, Doctors and Telemedicine. Its legal entity is PanGenomic Health Inc. Its competitors include Dialogue, Cognito and Inkblot; 2 of its 3 listed competitors have raised funding.
Company details
PanGenomic was founded in 2020 in Vancouver, Canada, within the healthcare sector. An online platform is operated to connect patients and providers through teleconsultation services focused on plant-based mental health therapies and treatments. Users are enabled to explore options from healthcare professionals via an application. Health progress is tracked, followed, and planned using the apps features.
- Headquarters Vancouver, Canada
- Founders Vincent Lum, Robert Nygren
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pangenomic.com
- Social LinkedIn X Facebook Instagram
- Legal Name Pangenomic Health, Inc. Class A
- Net Profit-$2.51 M (USD)9.79as on Dec 31, 2025
- EBITDA-$2.5 M (USD)-199.03as on Dec 31, 2025
- Latest Funding Round$1.43M (USD), Post-IPO
Dec 2025
- Investments & Acquisitions
Products & Services of PanGenomic
PanGenomic offers a comprehensive portfolio of products and services, including Nara, Mindleap, PlantGx, and MUJN Diagnostics.
App for curating natural remedies to manage mental wellness.
App providing audio content and tracking for mental well-being support.
Platform delivering personalized natural remedy regimens.
Tool for biomarker testing and patient symptom tracking.
Funding Insights of PanGenomic
- Total Rounds 4
- Last Round Post-IPO — $1.43M
All 4 funding rounds of PanGenomic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2025 | $1.43M | Post-IPO | – | – | – |
| Jan 2025 | $519,675 | Post-IPO | – | – | – |
| May 2024 | Post-IPO | – | – | – | |
| Dec 2022 | Post-IPO | – | – | – |
People of PanGenomic
3 people are tracked at PanGenomic (3 in leadership).
| Name | Role | Group |
|---|---|---|
Vincent Lum | Co-Founder & CEO | Leadership |
Robert Nygren | Co-Founder | Leadership |
Maryam Marissen | CEO | Leadership |
Complete people profiles for PanGenomic
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of PanGenomic
PanGenomic is a publicly listed company on the CSE with ticker symbol NARA in Canada, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Jul 2022
- Listed onCSE: NARA
- Listed entityPanGenomic Health, Inc. Class A
- Exchange sectorTechnology services
- ISINCA69842E4031
- Share price0.16 CAD (-36% on the day) · 2026-10-09
- Market capitalisation2,247,499.00 CAD
- EPS (diluted, trailing year)-0.21 CAD
- Volume (last session)500
Financials of PanGenomic
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | -3.4M CAD | -3.4M CAD | |
| 2024 | -3.8M CAD | -1.1M CAD | |
| 2023 | -3.0M CAD | -2.9M CAD | |
| 2022 | -12.0M CAD | -3.6M CAD | |
| 2021 | -2.6M CAD | -866,530 CAD |
Detailed financial statements for PanGenomic
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PanGenomic
PanGenomic has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MindLeap.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Mindfulness sessions for mental health are delivered via mobile app. | mindleap.com | Vancouver, Canada | 2019 | Sep 2022 | $2.75M |
Complete acquisition details for PanGenomic
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PanGenomic
5 dated milestones of PanGenomic across 5 years, from founding to its latest funding, stage changes and deals.
- Founded PanGenomic is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires MindLeap.
- Funding First funding round.
- Funding Latest funding round, Post-IPO, of $1.4M.
Competitors of PanGenomic
PanGenomic has 3 listed competitors in our database, 2 of them funded. They include Dialogue, Cognito and Inkblot.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dialogue.co | 2016 | Montreal, Canada | $88.16M | Dialogue is recognized as a leading health and wellness provider in Canada. | ||
| getcognito.ca | 2021 | Victoria, Canada | $2.88M | Online mental health consultations and therapy sessions are facilitated. | ||
| inkblottherapy.com | 2015 | Toronto, Canada | Teleconsultation with therapists is enabled via an online matching platform. |
Detailed competitors of PanGenomic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pangenomic
Complete news archive for PanGenomic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PanGenomic
PanGenomic was founded in 2020 and raised its 1st funding round 2 years after it was founded.
PanGenomic is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Vincent Lum is the CEO of PanGenomic, as recorded in our data. They have also founded this company.
PanGenomic was founded in 2020 in Vancouver, Canada, within the healthcare sector. An online platform is operated to connect patients and providers through teleconsultation services focused on plant-based mental health therapies and treatments. Users are enabled to explore options from healthcare professionals via an application. Health progress is tracked, followed, and planned using the apps features.
PanGenomic offers Nara, Mindleap, PlantGx, and MUJN Diagnostics.
Yes, PanGenomic is publicly traded on CSE under the ticker symbol NARA.
PanGenomic has made 1 acquisition, including MindLeap.
PanGenomic operates through Pangenomic Health Inc..